Open Tender Watch
Menu v
ACCESS EN PT
← Companies Company PT

GENERIS - FARMACÊUTICA, S.A.

NIF 508107997
↓ CSV ↓ JSON
Risk Flags
A1 · Repeat Direct Award €7,043,573 118 contracts
Same supplier receives ≥2 direct awards in 36 months with cumulative value above the CCP Art. 113 §2 statutory cap
HIGH €7,043,573 118 contracts
A2 · Late Publication €18,355,902,852 10,381 contracts
Contract published to BASE more than 10 days after the signing date
LOW €18,355,902,852 10,381 contracts
A5 · Threshold Splitting €75,736,676 296 contracts
Contract value falls within 5% below a procedural threshold (€5K / €20K / €75K / €150K / €5.35M). Score: 35 · Severity: Medium.
HIGH €75,736,676 296 contracts
A6 · Low Competition €155,761 16 contracts
Only one bidder participated in a competitive procedure
MEDIUM €155,761 16 contracts
A9 · Price Overrun €13,267 6 contracts
Effective price exceeds base price by >50% (score 30) or >100% (score 55); or effective price is <50% of base (score 10, possible predatory bid or data error). Severity: Medium/High/Low.
HIGH €13,208 5 contracts
MEDIUM €59 1 contracts
A9 · Abnormal Price Reduction €23,077,439,427 7,694 contracts
Effective price exceeds base price by >50% (score 30) or >100% (score 55); or effective price is <50% of base (score 10, possible predatory bid or data error). Severity: Medium/High/Low.
LOW €23,077,439,427 7,694 contracts
C3 · Missing Mandatory Fields €4,915,950 219 contracts
CPV code, procedure type, or base price absent for the procedure type, or base price exceeds ±€1 trillion (implausible data entry). Score: 20 · Severity: Low.
LOW €4,915,950 219 contracts

Procurement Network

Aggregated links between this entity and connected counterparties

Public view excludes person-level links and tax identifiers.

Loading network…
Legend Focus entity Public body Company Anonymized individual

Contracts by Contracting Authority

1,254
€2,475,643,734
1,539
€914,742,692
274
€823,251,857
408
€813,806,885
529
€768,429,168
245
€750,719,182
451
€748,806,350
92
€744,650,011
189
€706,536,301
557
€702,514,605
549
€686,966,748
92
€685,711,811
1,075
€683,061,340
153
€671,715,271
155
€656,636,220
357
€648,520,132
155
€643,716,446
213
€640,246,758
154
€635,157,566
212
€619,921,591
Page 1 of 4 · 73 authorities
Next →

All Contracts Won

Signal: All A1 · Repeat Direct Award A2 · Late Publication A5 · Threshold Splitting A6 · Low Competition A9 · Price Overrun A9 · Abnormal Price Reduction C3 · Missing Mandatory Fields

Page 1 of 6 · 296 contracts

050100812026 - C/ BASE NO CPA 2025_1589
PT · 13701536 · Ao abrigo de acordo-qu...
A5 · Threshold Splitting A2 · Late Publication
€4,840 2026-02-16
261Y000018 para 2026 - CPA 2025/1367 - Medicamentos do aparelho digestivo
PT · 13098380 · Ao abrigo de acordo-qu...
A5 · Threshold Splitting A9 · Abnormal Price Reduction
€144,301 2026-02-03
Medicamentos usados em afeções oculares e otorrinolaringológicas
PT · 13153543 · Ao abrigo de acordo-qu...
A5 · Threshold Splitting A2 · Late Publication +1
€19,203 2026-01-21
Medicamentos usados em afeções oculares e otorrinolaringológicas
PT · 13153217 · Ao abrigo de acordo-qu...
A5 · Threshold Splitting A2 · Late Publication +1
€19,203 2026-01-21
050100122026 - C/ BASE NO CPA 2023_436 - MÁQUINA DE REEMBALAGEM - PROUD
PT · 12798702 · Ao abrigo de acordo-qu...
A5 · Threshold Splitting A2 · Late Publication +1
€19,471 2026-01-07
CPA 2023/492 - Medicamentos anti-infeciosos
PT · 13071712 · Ao abrigo de acordo-qu...
A5 · Threshold Splitting A2 · Late Publication +1
€19,760 2025-12-30
MEDICAMENTOS ANTI-INFECIOSOS (SPMS 2023/492)- PC.04305.2025
PT · 12674939 · Ao abrigo de acordo-qu...
A5 · Threshold Splitting A2 · Late Publication +1
€19,500 2025-12-23
Aquisição de Medicamentos Diversos AQ2023/671 - Adicionais 3
PT · 11953565 · Ao abrigo de acordo-qu...
A5 · Threshold Splitting A2 · Late Publication +1
€74,789 2025-11-05
Q1/2318/2025 - AGREGAÇÃO URGENTE - MEDICAMENTOS DO FORO ONCOLÓGICO E IMUNOMODULADORES
PT · 11952474 · Ao abrigo de acordo-qu...
A5 · Threshold Splitting A2 · Late Publication +1
€5,294,078 2025-10-22
Aquisição de Medicamentos para o Sistema Nervoso Central
PT · 11819578 · Ao abrigo de acordo-qu...
A5 · Threshold Splitting A9 · Abnormal Price Reduction
€19,773 2025-10-16
41/4441/2025 Medicamento Quetiapina
PT · 11687029 · Ao abrigo de acordo-qu...
A5 · Threshold Splitting A9 · Abnormal Price Reduction
€4,800 2025-09-03
Aquisição de ACITRETINA 25 MG CÁPS, BETAMETASONA 1 MG/G CR BISN 30 G e BETAMETASONA 1 MG/G POM BISN 30 G
PT · 11659413 · Ao abrigo de acordo-qu...
A5 · Threshold Splitting A9 · Abnormal Price Reduction
€4,951 2025-08-21
PV/2078/2025 - MEDICAMENTOS DIVERSOS
PT · 11765402 · Consulta Prévia
A5 · Threshold Splitting A2 · Late Publication +1
€71,675 2025-08-13
060101052025 AQUISIÇÃO DE MEDICAMENTOS PARA AS NECESSIDADES IMEDIATAS DOS DOENTES-DESPACHO 1571-B/2016
PT · 11650718 · Ao abrigo de acordo-qu...
A5 · Threshold Splitting A2 · Late Publication
€73,528 2025-08-08
ADCM 3413/25 - MEDICAMENTOS DIVERSOS
PT · 11641210 · Ajuste Direto Regime G...
A5 · Threshold Splitting
€4,995 2025-08-07
Acordo Quadro para fornecimento de Medicamentos anti-infeciosos, na área da Saúde – CP 2023/492 – SPMS
PT · 11732133 · Ao abrigo de acordo-qu...
A5 · Threshold Splitting A2 · Late Publication +1
€71,952 2025-06-20
Acordo Quadro para fornecimento de Medicamentos anti-infeciosos, na área da Saúde – CP 2023/492 – SPMS
PT · 11732062 · Ao abrigo de acordo-qu...
A5 · Threshold Splitting A2 · Late Publication +1
€71,952 2025-06-20
Medicamentos
PT · 11532569 · Ajuste Direto Regime G...
A5 · Threshold Splitting A2 · Late Publication +1
€19,310 2025-06-12
Aquisição de Anti-Psicóticos, Anestésicos e Relaxantes Musculares - AQ2022/19 SPMS
PT · 11639534 · Ao abrigo de acordo-qu...
A5 · Threshold Splitting A2 · Late Publication +1
€148,515 2025-05-08
Medicamentos
PT · 11371294 · Ajuste Direto Regime G...
A5 · Threshold Splitting A9 · Abnormal Price Reduction
€72,968 2025-04-17
ADCM 1762/25 - MEDICAMENTOS DIVERSOS
PT · 11484413 · Ajuste Direto Regime G...
A5 · Threshold Splitting A2 · Late Publication +1
€74,912 2025-04-14
Aquisição de Medicamentos do foro oncológico e imunomoduladores, ao abrigo do acordo quadro 2023/491, para o ano 2025
PT · 11748908 · Ao abrigo de acordo-qu...
A5 · Threshold Splitting A2 · Late Publication +1
€144,806 2025-04-10
VÁRIOS MEDICAMENTOS
PT · 11334584 · Ajuste Direto Regime G...
A5 · Threshold Splitting A1 · Repeat Direct Award
€19,853 2025-04-03
Aquisição de Medicamentos analgésicos, antipiréticos e antidepressivos, ao abrigo do CPA 2024/898
PT · 11367048 · Ao abrigo de acordo-qu...
A5 · Threshold Splitting A2 · Late Publication +1
€146,162 2025-03-27
VÁRIOS MEDICAMENTOS
PT · 11316574 · Ajuste Direto Regime G...
A5 · Threshold Splitting A1 · Repeat Direct Award
€19,154 2025-03-25
VÁRIOS MEDICAMENTOS
PT · 11317056 · Ao abrigo de acordo-qu...
A5 · Threshold Splitting
€71,746 2025-03-24
ANTIEPILETICOS E ANTICONVULSIONANTES
PT · 11296555 · Ao abrigo de acordo-qu...
A5 · Threshold Splitting A9 · Abnormal Price Reduction
€147,161 2025-03-20
4525700250 | LM 021/2025 | Acordo Quadro para fornecimento de medicamentos para o sistema nervoso central, na área da saúde CP 2023/436 – SPMS
PT · 11320066 · Ao abrigo de acordo-qu...
A5 · Threshold Splitting A2 · Late Publication +1
€4,876 2025-03-17
HIDROCORTISONA 100 MG PÓ SOL INJ FR IM IV - Consulta Prévia N.º 11046325
PT · 11630930 · Ao abrigo de acordo-qu...
A5 · Threshold Splitting A2 · Late Publication
€19,720 2025-03-14
Aquisição de ABACAVIR 300 MG COMP
PT · 11313944 · Ao abrigo de acordo-qu...
A5 · Threshold Splitting A2 · Late Publication
€19,080 2025-03-13
PROGRAMA NACIONAL DE SAUDE REPRODUTIVA 2025_1299_2025
PT · 11282079 · Ao abrigo de acordo-qu...
A5 · Threshold Splitting
€74,519 2025-03-11
BEAD20250080 - AQUISIÇÃO DE CITOTOXICOS
PT · 11273765 · Ao abrigo de acordo-qu...
A5 · Threshold Splitting A9 · Abnormal Price Reduction
€72,875 2025-03-07
MEDICAMENTOS
PT · 11313180 · Ajuste Direto Regime G...
A5 · Threshold Splitting A2 · Late Publication +1
€19,131 2025-02-21
Aquisição de Medicamentos do aparelho geniturinário (AQ2023495)
PT · 11261432 · Ao abrigo de acordo-qu...
A5 · Threshold Splitting A2 · Late Publication +1
€72,585 2025-02-20
Aquisição de Medicamentos diversos ao abrigo do CPA 2023/671 para a ULSASI para o ano 2025
PT · 11223154 · Ao abrigo de acordo-qu...
A5 · Threshold Splitting A9 · Abnormal Price Reduction
€148,488 2025-02-13
Medicamentos diversos V
PT · 11317866 · Ao abrigo de acordo-qu...
A5 · Threshold Splitting A2 · Late Publication +1
€74,578 2025-02-10
Medicamentos diversos III
PT · 11316946 · Ao abrigo de acordo-qu...
A5 · Threshold Splitting A2 · Late Publication +1
€19,895 2025-01-20
VÁRIOS MEDICAMENTOS
PT · 11191927 · Ao abrigo de acordo-qu...
A5 · Threshold Splitting
€71,862 2025-01-20
251A000007 - Medicamentos anti-infeciosos
PT · 11164008 · Concurso público
A5 · Threshold Splitting A9 · Abnormal Price Reduction
€74,618 2025-01-15
Medicamentos
PT · 11324941 · Ajuste Direto Regime G...
A5 · Threshold Splitting A2 · Late Publication +1
€74,849 2025-01-08
PQ/197/2025
PT · 11538192 · Ao abrigo de acordo-qu...
A5 · Threshold Splitting A2 · Late Publication +1
€19,447 2025-01-06
AQUISIÇÃO DE MEDICAMENTOS USADOS EM AFECÇÕES OCULARES E OTORRINOLARINGÓGICAS PARA O ANO DE 2025
PT · 11125755 · Ao abrigo de acordo-qu...
A5 · Threshold Splitting A9 · Abnormal Price Reduction
€148,752 2025-01-03
VÁRIOS MEDICAMENTOS
PT · 11219229 · Ao abrigo de acordo-qu...
A5 · Threshold Splitting C3 · Missing Mandatory Fields
€73,545 2024-12-23
MEDICAMENTOS
PT · 11130058 · Ajuste Direto Regime G...
A5 · Threshold Splitting A2 · Late Publication +1
€74,145 2024-12-18
251000016 - MEDICAMENTOS DIVERSOS
PT · 11095144 · Ao abrigo de acordo-qu...
A5 · Threshold Splitting A9 · Abnormal Price Reduction
€147,343 2024-12-13
Medicamentos diversos ao abrigo do AQ 2022/173 dos SPMS, para o Ano 2025
PT · 11873617 · Ao abrigo de acordo-qu...
A5 · Threshold Splitting C3 · Missing Mandatory Fields
€4,868 2024-12-12
251000020- Medicamentos Diversos
PT · 11109026 · Ao abrigo de acordo-qu...
A5 · Threshold Splitting A2 · Late Publication +1
€142,919 2024-12-11
Aquisição de FINGOLIMOD, ORAL, 0,5MG CAP, para a ULSASI, para o ano 2024
PT · 11073449 · Consulta Prévia
A5 · Threshold Splitting
€4,795 2024-12-09
CINACALCET 30MG e 60MG COMP (PC.03347.2024)
PT · 11014856 · Ao abrigo de acordo-qu...
A5 · Threshold Splitting A2 · Late Publication
€19,033 2024-10-14
MEDICAMENTOS
PT · 10979959 · Ajuste Direto Regime G...
A5 · Threshold Splitting A9 · Abnormal Price Reduction
€71,694 2024-10-09
Next →
Overview
Total Value Won
€23,189,380,103
Contracts Won
14,458
Score 513445 · CRITICAL RISK
NIF
508107997
Country
PT
Directors & Officers

Personal data is pseudonymised for public access. Authenticate with a journalist token to view full names and NIFs.

  • A.C. [P-6b27]
    Vogal
    since 2009-01-27
  • B.T. [P-5d15]
    Vogal
    since 2013-06-18
  • B.V. [P-41c8]
    Vogal
    since 2022-11-21
  • B.V. [P-41c8]
    Vogal
    since 2024-07-02
  • B.M. [P-4414]
    Vogal
    since 2013-06-18
  • D.A. [P-c2b1]
    Administrador
    since 2024-07-02
  • J.M. [P-4b91]
    Vogal
    since 2021-02-17
  • J.M. [P-4b91]
    Vogal
    since 2024-07-02
  • J.P. [P-a3d6]
    Vogal
    since 2024-07-02
  • J.M. [P-8a35]
    Presidente
    since 2013-06-18
  • J.D. [P-6dab]
    Vogal
    since 2009-01-27
  • J.L. [P-4e77]
    Vogal
    since 2009-01-27
  • J.P. [P-e7f5]
    Vogal
    since 2009-01-27
  • L.S. [P-58df]
    Presidente
    since 2021-02-17
  • L.S. [P-58df]
    Presidente
    since 2024-07-02
  • L.M. [P-cd63]
    Vogal
    since 2020-05-22
  • L.M. [P-cd63]
    Vogal
    since 2021-02-17
  • L.M. [P-cd63]
    Vogal
    since 2024-07-02
  • P.M. [P-976f]
    Administrador delegado - nomeado por cooptação
    since 2010-07-22
  • P.M. [P-976f]
    Vogal
    since 2013-06-18
  • P.P. [P-9c70]
    vogal
    since 2017-04-28
  • R.I. [P-424a]
    Vogal
    since 2021-02-17
  • R.I. [P-424a]
    Vogal
    since 2024-07-02
  • S.I. [P-c50b]
    Presidente
    since 2017-04-28
  • S.I. [P-c50b]
    Presidente
    since 2021-02-17
  • S.B. [P-2395]
    Vogal
    since 2019-05-15
  • S.B. [P-2395]
    Vogal
    since 2021-02-17
  • S.B. [P-2395]
    Vogal
    since 2024-07-02
  • V.M. [P-4ee7]
    vogal
    since 2017-04-28
  • V.M. [P-4ee7]
    Vogal
    since 2021-02-17
  • V.M. [P-4ee7]
    Presidente
    since 2024-07-02
  • C.L. [P-db3e]
    Fiscal Único
    since 2010-10-07
  • D.A. [P-c2b1]
    Fiscal Único
    since 2010-10-07
  • N.M. [P-c64f]
    Fiscal Único
    since 2009-01-19
  • P.R. [P-24a4]
    Fiscal Único
    since 2009-01-19
  • M.J. [P-082f]
    Sócio
    since 2007-09-20
  • P.M. [P-5bef]
    Sócio
    since 2007-09-20
  • A.C. [P-6b27]
    Vogal
    2013-06-18 → 2016-10-03
  • A.P. [P-d6ac]
    Vogal
    2009-01-27 → 2012-04-02
  • B.D. [P-3fbe]
    Vogal
    2009-01-27 → 2010-07-22
  • J.D. [P-6dab]
    Vogal
    2013-06-18 → 2016-12-29
  • J.P. [P-141b]
    Vogal
    2009-01-27 → 2010-07-21
  • J.L. [P-4e77]
    Presidente
    2013-06-18 → 2017-04-28
  • J.P. [P-e7f5]
    Vogal
    2013-06-18 → 2017-04-28
  • M.P. [P-7d24]
    vogal
    2017-04-28 → 2018-03-16
  • P.M. [P-976f]
    Vogal
    2017-04-28 → 2020-05-22
  • P.M. [P-63d9]
    Administrador
    2012-11-09 → 2013-03-06
  • P.M. [P-b036]
    Vogal
    2018-06-12 → 2019-05-15
  • P.P. [P-9c70]
    Vogal
    2021-02-17 → 2022-09-29
  • P.M. [P-be5a]
    Presidente
    2009-01-27 → 2010-07-21
  • N.M. [P-c64f]
    Fiscal Único
    until 2010-08-31
  • P.R. [P-24a4]
    Fiscal Único
    until 2010-08-31
Ownership & Registries

Beneficial ownership data (shareholders, directors, ultimate beneficial owners) is not yet imported. Links below open external public registries.

Registo Comercial (MJ) ↗ RCBE — Beneficial Ownership Register ↗

Full RCBE access requires judicial authentication (CJEU 2022 ruling limits public exposure).

Search in TED (EU procurement) ↗
Phase 7 — ownership layer planned